Form 424B4 - Prospectus [Rule 424(b)(4)]:
SEC Accession No. 0001193125-23-191569
Filing Date
2023-07-24
Accepted
2023-07-21 19:14:44
Documents
18

Document Format Files

Seq Description Document Type Size
1 424B4 d574486d424b4.htm 424B4 2740305
2 GRAPHIC g574486g08p42.jpg GRAPHIC 41709
3 GRAPHIC g574486g08r30.jpg GRAPHIC 52565
4 GRAPHIC g574486g24a01.jpg GRAPHIC 95453
5 GRAPHIC g574486g24a02.jpg GRAPHIC 665453
6 GRAPHIC g574486g25s01.jpg GRAPHIC 146378
7 GRAPHIC g574486g25s02.jpg GRAPHIC 77841
8 GRAPHIC g574486g25s03.jpg GRAPHIC 110770
9 GRAPHIC g574486g25s04.jpg GRAPHIC 70236
10 GRAPHIC g574486g25s05.jpg GRAPHIC 48296
11 GRAPHIC g574486g25s06.jpg GRAPHIC 73128
12 GRAPHIC g574486g25s07.jpg GRAPHIC 83863
13 GRAPHIC g574486g27a01.jpg GRAPHIC 146291
14 GRAPHIC g574486g29a01.jpg GRAPHIC 105835
15 GRAPHIC g574486g31a01.jpg GRAPHIC 66797
16 GRAPHIC g574486g33a01.jpg GRAPHIC 174834
17 GRAPHIC g574486g35a01.jpg GRAPHIC 121931
18 GRAPHIC g574486g37a01.jpg GRAPHIC 362014
  Complete submission text file 0001193125-23-191569.txt   6029052
Mailing Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010
Business Address 920 BROADWAY 16TH FLOOR NEW YORK NY 10010 347-897-5988
Turnstone Biologics Corp. (Filer) CIK: 0001764974 (see all company filings)

EIN.: 832909368 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B4 | Act: 33 | File No.: 333-272600 | Film No.: 231103500
SIC: 2836 Biological Products, (No Diagnostic Substances)